Astrazeneca Pharma India Q4 Results

  • BSE: 506820
  • NSE: ASTRAZEN
  • ISIN: INE203A01020
  • Sector: Major Drugs
BSE
9,159.0070.00 (0.77%)
Volume187.00
Updated: Thu 4 Dec, 2025 | 15:29:27
NSE
9,154.0036.00 (0.39%)
Volume7.41 K
Updated: Thu 4 Dec, 2025 | 15:29:27
Today: 9,089.80
9,240.00
52-Wk: 6,301.00
10,653.05

Technical Trends

Long Term
Considers price movement over the last 6 months

Long Term
Not Available

Short Term
Considers price movement over the last 1-2 weeks

Not Available
  • Bearish
  • Moderately Bearish
  • Neutral
  • Moderately Bullish
  • Bullish

Insight: Trends unavailable at the moment.

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Astrazeneca Pharma India Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 25Dec 24QoQ CompMar 24YoY Comp
    Total Operating Expense 417.48405.922.85%337.5723.67%
    Depreciation/ Amortization 17.699.0795.04%3.76370.03%
    Operating Income 63.0034.3783.30%45.6338.07%
    Net Income 58.2530.8588.82%39.4847.55%
    Other Operating Expenses Total 47.3531.3351.13%36.9628.12%
    Net Income Before Taxes 78.4742.0286.74%54.3644.36%
    Total Revenue 480.48440.299.13%383.2025.39%
    Selling/ General/ Admin Expenses Total 87.1584.942.60%83.304.62%
    Diluted Normalized EPS 25.0122.1912.68%15.7958.34%

    EQUITY QUICK LINKS

    FROM MARKETS

    RELATED LINKS

    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market

          ✕

          Wait for it…

          Log in to our website to save your bookmarks. It'll just take a moment.

          ✕

          Wait for it…

          Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.